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Intracellular DNA and RNA sensors play a vital part in the innate immune response 
to viruses and other intracellular pathogens, causing the secretion of type I 
interferons, cytokines and chemokines from infected cells. Pathogen RNA can be 
detected by RIG-I-like receptors in the cytosol, while cytosolic DNA is recognised by 
DNA sensors such as cyclic GMP-AMP synthase (cGAS). The resulting local 
immune response, which is initiated within hours of infection, is able to eliminate 
many pathogens before they are able to establish an infection in the host. For this 
reason, all viruses, and some intracellular bacteria and protozoa, need to evade 
detection by nucleic acid sensors. Immune evasion strategies include the 
sequestration and modification of nucleic acids, and the inhibition or degradation of 
host factors involved in innate immune signalling. Large DNA viruses, such as 
herpesviruses, often use multiple viral proteins to inhibit signalling cascades at 
several different points; for instance Herpes Simplex Virus 1 (HSV-1) targets both 
DNA sensors cGAS and IFI16, as well as the adaptor protein STING and other 
signalling factors in the pathway. Viruses with a small genome enocde only few 
immunomodulatory proteins, but these are often multifunctional, such as the NS1 
protein from Influenza A virus which inhibits RNA sensing in multiple ways. 
Intracellular bacteria and protozoa can also be detected by nucleic acid sensors. 
However, as the type I interferon response is not always beneficial for the host under 
these circumstances, some bacteria subvert, rather than evade, these signalling 









Our innate immune system provides a rapid, if relatively non-specific, response to 
invading pathogens. The cornerstones of innate immunity are the pattern recognition 
receptors (PRRs), which detect pathogen-associated molecular patterns (PAMPs) 
during infection. PAMPs are key molecular features shared by classes of pathogens 
that are usually absent from healthy cells, and include for instance bacterial or fungal 
cell wall components, or viral nucleic acids which would not usually be found in the 
host cell. PAMPs can be recognised in trans when phagocytes detect engulfed 
pathogens or debris from infected cells via Toll-like receptors (TLRs) on their cell 
surface or inside endosomes. In addition, many cell types can also recognise when 
they have been infected themselves by an intracellular pathogen using intracellular 
PRRs that constantly survey the cell's contents for signs of infection. Intracellular 
PRRs raise the alarm either after sensing the presence of PAMPs directly, or after 
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detecting the indirect effects of infection or tissue damage as danger-associated 
molecular pattern (DAMP)1.  
 Intracellular nucleic acid sensors are PRRs that can perform both those 
functions: they can recognise pathogen-derived DNA or RNA species inside the cell, 
and also detect nucleic acids as danger signal, for instance when infection leads to 
the leakage of mitochondrial DNA or RNA into the cytosol. Intracellular nucleic acid 
receptors are particularly important in the detection of viruses, which lack many other 
conspicuous features such as the unique cell wall components of bacteria or 
protozoa. However, nucleic acids are starting to emerge as key mediators during the 
innate immune response to a range of pathogens, including intracellular bacteria and 
protozoa.  
 In this review we will focus on the intracellular DNA and RNA sensors that 
induce a transcriptional response leading to the production of interferons, cytokines 
and chemokines. The rapidly inducible transcriptional program is a key factor in the 
early elimination of pathogens and for the initiation of appropriate local immune 
responses that ultimately determines the outcome of an infection. For this reason, it 
can be assumed that all pathogens need to evade or subvert the host's innate 
immune responses in order to be able to establish an infection. Here, we will 
describe the strategies that intracellular pathogens use to hide from the cell's nucleic 
acid receptors, and to disable or subvert their function. Ultimately, the activation of 
signalling cascades by nucleic acid sensors and many other PRRs converges on the 
activation of transcription factors such as NF-κB and IRF3. Many pathogens also 
block innate immune responses at the level of these downstream signalling nodes, or 
by inhibiting the function of interferons and cytokines after they have been secreted, 
and we refer the reader to further reviews on this topic2-4 
 
Detection of pathogens by RIG-I-like receptors (RLRs)  
      
The RIG-I-like receptors retinoic-acid inducible gene I (RIG-I) and melanoma 
differentiation-associated protein 5 (MDA5) recognise exogenous RNA in the cytosol 
of infected cells. RIG-I detects short stretches of dsRNA as well as RNA species 
containing a triphosphate or diphosphate moiety at their 5' end, and MDA5 
recognises long dsRNA molecules and higher order aggregates of viral dsRNA5. 
While the cytosol contains abundant cellular RNA molecules, these are not detected 
by RLRs. mRNAs contain a m7-guanosine cap at their 5' end, tRNAs are cleaved to 
generate a 5' monophosphate, and both tRNAs and rRNAs contain modifications 
which prevent recognition by RIG-I5. dsRNA regions, e.g. in stem loops of 
endogenous RNA molecules are usually short and contain frequent mismatches, 
further enhanced by ADAR1-mediated conversion of adenosine to inosine (A->I 
editing)6. In this way, RLRs are able to detect exogenous RNA molecules that may 
be present during infection in the presence of an abundance of cellular RNA in the 
cytosol. 
 Following detection of specific RNA ligands in the cytosol, RIG-I and MDA5 
undergo posttranslational modifications such as dephosphorylation and 
polyubiquitylation7 and signal via their caspase activation and recruitment domains 
(CARD) to the CARD domain-containing adaptor MAVS (mitochondrial anti-viral 
signalling protein), nucleating the assembly of prion-like MAVS filaments8. This 
results in the MAVS-mediated activation of the transcription factors IRF3 and NF-κB 
that co-operate in the activation of the IFN-β promoter. RLR signalling is further 
regulated by the addition of K48-linked and K-11 linked ubiquitin chains, which 
mediate the degradation of RIG-I and MAVS7,9 Termination of RLR signalling is also 
achieved by RIG-I phosphorylation preventing the ubiquitination of CARD domains10 
and MAVS dephosphorylation which impedes interaction with downstream signalling 
proteins11 To prevent spurious activity, RIG-I and MAVS exist in an autoinhibitory 
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state facilitated by the phosphorylation and sequestration of CARD domains in RIG-
I12,13 and the repression of signalling motifs by adjacent regions in MAVS14. Negative 
regulation of signalling is important to ensure that an innate immune response is 
transient, and does not cause extensive tissue damage.  
 RLRs have been implicated in the detection of many viruses, as well as other 
intracellular pathogens. Most viral RNA polymerases generate transcripts with 5' 
triphosphate ends and many viruses also generate dsRNA during their life cycle. 
Thus, both RIG-I and MDA5 are predicted to be able to detect the dsRNA genomes 
of reoviruses and the dsRNA replicative intermediates of the +ve strand ssRNA 
viruses of the Flaviviridae and Coronaviridae families15. RIG-I can also detect the 
short dsRNA panhandle structures containing a 5' triphosphate from -ve strand RNA 
viruses, such as Influenza A virus and Sendai virus16,17, and RNA with a 5' di-
phosphate ends, such as the genome of reoviruses18. MDA5, on the other hand, is 
specifically required for the detection of picornaviruses, that contain protein-capped 
+ve stranded RNA genomes, and generate long, structured dsRNA intermediates 
that can be detected by MDA5, but not RIG-I19-22. MDA5 also specifically detects 
ssRNA viruses of the Calicivirdae family, such as norovirus23,24. Several DNA viruses 
are also sensed by the RLRs, including herpes simplex virus 1, adenovirus, Modified 
Vaccinia virus Ankara and Epstein-Barr virus25-29 This is thought to be due to the 
convergent transcription of adjacent open reading frames generating dsRNA, and the 
transcription of structured RNAs by viral polymerases. RNA sensing can also 
contribute to the detection of intracellular bacteria, including Legionella pneumophila, 
Salmonella typhimurium and Shigella flexneri30-32. Furthermore, RNA sensors can 
also be activated by cellular RNA as positive feedback loop during infection: RNA 
fragments generated by the interferon-stimulated gene (ISG) RNaseL, unmasked 
ribosomal RNA transcripts or mitochondrial RNA that leaks into the cytosol can also 
be detected by RLRs25,33,34.  
  
Detection of exogenous DNA and cyclic di-nucleotides 
 
Many mammalian cell types can also detect exogenous DNA. Bacterial, viral or 
synthetic dsDNA, and even dsDNA isolated from mammalian cells, can be sensed, if 
it gains access to the cytosol and is over 40-50 bp in length5. The key sensor of 
cytosolic DNA that induces an interferon response is the enzyme cyclic GMP-AMP 
synthase (cGAS), which upon dsDNA binding catalyses the production of the second 
messenger 2'3'-cyclic-GMP-AMP (cGAMP)35. cGAMP then binds to the adaptor 
protein stimulator of interferon genes (STING), causing a conformational change in 
the STING dimers36. This is linked to the activation of STING, its translocation from 
the endoplasmic reticulum (ER) to peri-nuclear signalling foci, and the association 
with TBK1 and IRF336-38. TBK1 phosphorylates STING at Serine 366, which, in 
analogy to MAVS signalling, leads to the recruitment of IRF337. STING function is 
further regulated by palmitoylation, and modification with K63-, K48-, K11- and K27-
linked ubiquitin chains, and degradation by autophagy7.  
 Additional DNA binding proteins have been proposed to function as DNA 
sensors39. As cGAS is essential for the response to cytosolic DNA in most systems 
investigated so far, any other proposed DNA sensors may synergise with cGAS as 
co-receptors or co-factors, in order to further amplify the response or to provide an 
additional layer of specificity. This has been shown for the DNA binding protein 
interferon-γ-inducible protein 16 (IFI16), which co-operates with cGAS in the 
activation of STING in human cells40,41. In human cells, IFI16 may also be able to 
detect viral DNA in the nucleus, possibly by recognising unchromatinised ("naked") 
stretches of DNA to distinguish viral DNA from our own chromatin42-44. Another 
member of the PYHIN family, AIM2, has also been shown to detect DNA45-47. 
However, its downstream signalling diverges from IFI16 as it triggers inflammasome 
formation and IL-1β production. Other DNA sensors include DNA-dependent 
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activator of IFN-regulatory factors (DAI)48, DNA-dependent protein kinase (DNA-
PK)49  DExD/H-box helicases DHX9 and DHX3650 , DDX4151 and MRE1152. While 
several of these proteins have been observed to be important for the induction of an 
interferon response after detection of cytosolic DNA, their molecular role in the 
context of the cGAS-STING signalling axis remains to be deyermined.  
 The cytosolic DNA sensing pathway has been shown to be crucial for the 
detection of many different DNA viruses and retroviruses53,54. Surprisingly, some 
RNA viruses such as Dengue virus also engage the DNA sensing machinery by 
causing mitochondrial damage, resulting in the release of mitochondrial DNA into the 
cytosol55. STING-dependent DNA sensing has also shown to be involved in the 
detection of DNA from protozoa such as Plasmodium falciparum and intracellular 
bacteria including Mycobacterium tuberculosis and Listeria monocytogenes56-59.  
 During bacterial infection, the DNA sensing adaptor STING has a second 
function and can act as a PRR in its own right. STING can sense bacterial signalling 
molecules such as cyclic di-GMP and cyclic di-AMP60,61. Like cGAMP, these cyclic di-
nucleotides can bind and activate STING and induce the production of type I 
interferons, which has been observed e.g. during infection with Mycobacterium 
tuberculosis and Listeria monocytogenes61-63. Thus bacteria can activate a STING-
dependent innate immune response by two different means, even though the 
resulting production of type I interferons is not always beneficial for the host, but 
instead can serve as an immune diversion strategy for some bacteria63,64. 
  
Immune evasion strategies employed by intracellular pathogens 
 
Pathogens and their hosts co-evolve, and there are clear signs of selective pressure 
on host factors such as DNA and RNA sensors on one hand and pathogen-encoded 
immune evasion proteins on the other65-67. Immunomodulatory proteins and virulence 
factors are finely tuned to adapt to the host range and life cycle of the pathogen. The 
precise interplay between host and pathogen factors is often unique, and can differ in 
different host organisms, cell types and amongst even closely related pathogens. 
However, mapping these host-pathogen interactions at a molecular level can provide 
clues about the importance of host signalling cascades, can help us understand 
changes in species specificity and virulence of emerging pathogens, and aid in the 
design of vaccine vectors. As PRR signalling pathways are being characterised in 
more molecular detail, the intricate counter-strategies employed by pathogens to 
evade recognition are also becoming apparent. Some general principles by which 
intracellular pathogens hide from detection or intercept the cell's signalling cascades 
are described below.  
 
1. Sequestration of PAMPs 
 
Pathogens that reside inside host cells are already sheltered from the immune 
system to some extent, by avoiding exposure to antibodies or complement 
components. However, due to the existence of intracellular PRRs, additional 
camouflage strategies are essential for the establishment of infection. Intracellular 
bacteria and protozoan parasites often co-opt vacuoles as a niche for replication, 
which prevents pathogen-derived nucleic acids and other PAMPs from being 
exposed to the cell's PRRs. Thus, detection of intracellular nucleic acids during 
bacterial infection often requires the presence of bacterial secretion systems. For 
instance, the type VII secretion system ESX from Mycobacterium tuberculosis is 
responsible for the exposure of bacterial DNA to cGAS in macrophages, but also 
secretes virulence factors that interfere with host functions56,68. Viruses require 
greater access to host factors for replication than bacteria, but also try to shield their 
nucleic acids from detection. Some RNA viruses, including Dengue virus and 
Hepatitis C viruses (HCV) sequester their genome and replication machinery in 
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membrane-bound compartments, which function to create locally high concentration 
of replication factors, as well as hiding viral RNA genomes from recognition by RIG-
I69,70. HIV-1 carries out reverse transcription and replication of its genome inside its 
capsid, which contains selective pores to allow entry for nucleotides from the host 
cell, while shielding viral DNA from recognition by cGAS71.  
 
2. Modification of viral RNA and DNA 
 
Many pathogens aim to keep PAMP levels at a minimum: coronaviruses for instance 
quickly degrade any excessive dsRNA formed during the viral life cycle72, and Group 
B Streptococcus degrades cyclic di-AMP using an ectonuclease73. However, the 
production of nucleic acid PAMPS cannot be avoided altogether, and thus more 
sophisticated strategies of camouflage have evolved, so that the pathogen can blend 
in to the cellular environment. 
 As viral RNA polymerases generate RNA species with a 5' triphosphate 
moiety, many viruses employ additional strategies to modify their RNA, so that it is 
not recognised efficiently by RIG-I. For instance, Picornaviridae, Caliciviridae and 
Astroviridae covalently attach a protein, Vpg, to the 5' end of viral RNAs, which 
prevents RIG-I-mediated recognition15.  Processing of the -ve strand ssRNA genome 
of members of the Bornaviridae and Bunyaviridae families involves the cleavage of 
the first nucleotide by a viral endonuclease to generate a monophosphate group at 
the 5' end74. Viruses that transcribe their mRNAs in the nucleus, including the DNA 
viruses of the Herpesviridae and Papillomaviridae families and retroviruses such as 
HIV, co-opt the cell's own capping machinery to protect the 5' end of their mRNAs 
with a 7-methylguanosine cap, while others, including Influenza A virus, use "cap 
snatching" to remove the capped 5' ends from cellular mRNAs and incorporate them 
into viral RNA transcripts75. Many viruses, including poxviruses and flaviviruses, 
encode their own capping enzymes that synthesise RNA caps which are 
indistinguishable from the mammalian cap structure75. Yellow Fever virus in addition 
recapitulates the 2'O-methylation of the first RNA nucleotide next to the cap, which is 
found in cellular mRNAs and further decreases recognition by RIG-I76. Bacteria and 
protozoa also cap their mRNAs, but not always with 100% efficiency. RNA derived 
from intracellular bacteria can activate the RNA sensing pathway if it reaches the 
cytosol, but it remains to be determined whether this is important during infection77.  
 So far, it is not known whether DNA modifications could prevent recognition 
by cGAS or other DNA sensors. It has been proposed that IFI16 may be able to 
distinguish viral DNA from the cell's own genome by recognising longer (>40nt) 
stretches of free DNA43,44, and the detection of DNA by cGAS has also been shown 
to be length-dependent78. It remains to be tested whether the assembly of 
nucleosomes on the genomes of DNA viruses such as herpesviruses and 
papillomaviruses could be a strategy to limit their detection by intracellular DNA 
sensors.  
 
3. Degradation and inhibition of host signalling factors 
 
All intracellular pathogens encode virulence factors that interfere with the host's 
signalling cascades. Viral immunomodulatory proteins are usually expressed as 
immediate early genes, or are even part of the viral particle, so that they are able to 
inhibit the host's signalling cascades as soon as PAMPs are detected early in 
infection. Intracellular bacteria employ secretion systems to transport effector 
proteins through the vacuolar and bacterial membranes into the host cell, while 
protozoans can secrete virulence factors via exosomes or other membrane-bound 
vesicles. A vast repertoire of virulence factors that influence the cell's innate immune 
signalling cascades have been described, particularly in viruses, which often 
dedicate a large portion of their genome to interfering with the host's innate immune 
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response. While many viruses encode only few proteins, these are often multi-
functional and target several key host factors. Large DNA viruses, such as 
poxviruses and herpesviruses, encode a larger repertoire of dozens of 
immunomodulatory proteins which interfere with anti-viral signalling cascades in the 
cell at multiple points79,80. Bacteria and protozoa encode thousands of genes, and 
thus have an even greater capacity to interfere with host functions, but comparatively 
few immune evasion proteins have been described so far, with many pathogen-
encoded effector proteins still uncharacterised3,4,64.  
 Many pathogens have evolved similar strategies to inhibit the innate immune 
signalling cascades in the host cell: virulence factors act to either eliminate host 
signalling factors by degradation, sequester them or block their function in the 
signalling cascade. As we learn more about the regulation of innate immune 
signalling cascades that detect pathogens, more examples of counter-strategies 
employed by pathogens also emerge.  
 
3.1 Degradation and inhibition of RNA sensors 
 
Since the discovery of the intracellular RNA sensing system, many immune evasion 
proteins that target RLRs or MAVS have been identified (see figure 1), mostly in 
viruses with an RNA genome, for which RIG-I and/or MDA5 are the key PRRs during 
infection. Some viral proteases cleave RNA sensors, with several picornaviruses 
utilising their 3C protease to cleave RIG-I, and the 2A protease to cleave MDA581-83. 
The leader protease Lpro from foot and mouth disease virus (FMDV) also cleaves 
Lpg2, a co-factor for MDA5 activation84. Some viruses modify RLRs with K48-linked 
poly-ubiquitin chains, diverting the RNA sensors for degradation by the cell's 
proteasome. Toscana virus (TOSV) NSs and the rotavirus (RV) NSP1 protein cause 
the degradation of RIG-I85,86, while West Nile virus (WNV) NS1 targets both RIG-I 
and MDA587. RIG-I mRNA expression and translation can also be inhibited during 
viral infection: For instance, Epstein-Barr Virus (EBV) expresses the virus-encoded 
microRNA miR-BART6-3p which targets RIG-I mRNA88, and Hepatitis B virus (HBV) 
induces the cellular microRNA miR146a that inhibits RIG-I expression89.   
 Even under conditions where the expression of RIG-I and MDA5 is intact, the 
RNA sensors can be prevented from carrying out their signalling function by viral 
proteins that bind to them. The herpes simplex virus 1 (HSV-1) protein UL37 
interacts with RIG-I and causes the deamidation of its helicase domain, which 
renders RIG-I unable to sense RNA ligands90. Another HSV-1 protein, US11 inhibits 
RNA sensing by associating with the dsRNA binding protein PACT, which potentiates 
RNA-induced responses91,92. PACT is also targeted by Influenza A virus (IAV) NS1, 
the VP35 protein from Ebolavirus (EBOV) and the 4a protein from Middle East 
Respiratory Syndrome (MERS) coronavirus93-95. Many of the PACT-interacting 
proteins also bind dsRNA, so they likely shield the viral RNA from detection while at 
the same time inactivating PACT and RNA sensors.  
 The activity of RIG-I and MDA5 is tightly regulated in the cell: In the absence 
of infection, the CARD domains of the RNA sensors is kept in a phosphorylated 
state, and activation involves their dephosphorylation catalysed by protein 
phosphatase 1 (PP1)96. RIG-I activity is further enhanced by the assembly of K63-
linked poly-ubiquitin chains catalysed by the E3 ubiquitin ligases TRIM25 and Riplet 
which release RIG-I from its autoinhibited state97,98. Given the importance of these 
post-translational modifications, it is not surprising that many viruses have evolved 
ways of inhibiting these regulatory mechanisms. For instance, measles virus utilises 
an elaborate signalling strategy involving the activation of the C-type lectin DC-SIGN 
to inhibit the phosphatase PP1, thus keeping the RLRs phosphorylated and 
inactive99. The E3 ubiquitin ligase Riplet is inhibited by the multifunctional IAV NS1 
protein100 and cleaved by the NS3/4A protease from HCV101. Multiple viruses also 
inhibit TRIM25, including again IAV NS1, the SARS coronavirus N protein, the V 
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protein from various paramyxoviruses, BPLF1 from EBV and the E6 protein from 
human papillomavirus (HPV) 16 102-107. The subgenomic flavivirus RNA (sfRNA) from 
Dengue virus can also bind and inactivate TRIM25 in an RNA sequence-specific 
manner108. RIG-I ubiquitylation by TRIM25 is also inhibited by the bacterial quorum 
sensing molecule cyclo(Phe-Pro) from the opportunistic pathogen Vibrio vulnificus. 
Cyclo(Phe-Pro) specifically binds to RIG-I and prevents it from being ubiquitylated by 
TRIM25109, possibly providing a link between bacterial infection and susceptibility to 
co-infection with viruses. 
 A multitude of viral immunomodulators prevent RIG-I and MDA5 from 
interacting with its adaptor protein MAVS, thus blocking the nucleation event that 
allows MAVS to form higher order signalling assemblies. Dengue virus NS3 binds 
14-3-3ε to prevent the translocation of RIG-I to MAVS110. The interaction between 
RLRs and MAVS is also disrupted by the picornavirus 3Cpro proteases, the Z and N 
proteins of some arenaviruses, NS2 from respiratory syncytial virus (RSV), NS1 from 
Influenza A virus, NSP1 from rotavirus and US11 from HSV-116,86,111-114.  
 MAVS is also targeted directly by many viruses. MAVS-interacting proteins 
include the metapneumovirus protein M2-2115, the NS4A proteins of Zika and Dengue 
viruses116,117, viral IRF1 (vIRF1) from human herpesvirus 8 (HHV8)118 and ORF9b 
from SARS coronavirus119. MAVS is also diverted for proteasome-mediated 
degradation by the Hepatitis B virus (HBV) X protein120, and is cleaved by the HCV 
protease NS3/4A, which releases it from the mitochondria and other intracellular 
membranes to disrupt signalling121-124. The US9 protein from HSV-1 causes MAVS to 
leak from the mitochondria by disrupting the mitochondrial membrane potential125, 
and the IAV protein PB1-F2 decreases mitochondrial membrane potential causing 
mitochondrial fragmentation126,127. Disrupting mitochondrial physiology is common 
mechanism to block MAVS signalling. Infection with Dengue and Zika viruses causes 
mitochondrial elongation which also blocks MAVS function128. The sustained 
interferon production caused by MAVS signalling from the peroxisomes is inhibited 
by the MIA protein from hCMV and the VP16 protein from HSV-1118,129,130. 
 While there are abundant examples of inhibition of RNA sensing by 
pathogens, and in particular viruses, there is one instance where a pathogen actually 
enhances signalling by RIG-I and MDA5. The food-borne pathogen Salmonella 
typhimurium utilises its effector protein SopA, an E3 ubiquitin ligase, to ubiquitylate 
the host proteins TRIM56 and TRIM65, which in turn promote RIG-I and MDA5 
signalling131,132. This is an example of subversion, rather than evasion, of the 
interferon response, in line with the observation that the production of type I 
interferons can be advantageous to the pathogen, rather than the host, during some 
bacterial infections64.   
 
3.2 Degradation and inhibition of DNA sensors  
 
Even though the cGAS/STING DNA sensing pathway was only discovered relatively 
recently, several viral and bacterial virulence factors that target this pathway have 
already been discovered. The nuclear DNA viruses human cytomegalovirus (hCMV), 
HSV-1 and Kaposi's Sarcoma-associated Herpesvirus (KSHV) all target several key 
DNA sensing factors to prevent the detection of their genomic DNA. HSV-1 utilises 
its ICP27 protein to inhibit STING133. In addition, the E3 ubiquitin ligase ICP0 to 
cause the degradation of IFI16 protein, and the virion host shutoff protein UL41 
promotes the turnover of the mRNAs encoding IFI16 and cGAS42,134,135. In addition, 
the HSV-1 virion protein VP22 interacts with cGAS and inhibits its enzymatic 
activity136 and also interacts with AIM2 and blocks its oligomerisation137. HSV-1 
tegument protein UL37, which targets and deamidates RIG-I, also deamidates cGAS, 
impairing cGAMP synthesis138.  The deployment of different virulence factors to 
target several components of the DNA sensing pathway may be necessary to block 
the pathway more efficiently, and/or to inhibit some non-overlapping functions of 
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cGAS and IFI16 which have been observed during herpesvirus infection139. 
Analogously, several different hCMV proteins inhibit DNA sensing: pUL31 binds to 
cGAS and dissociates it from DNA140, pUL83 inhibits both cGAS and IFI16141-143, 
pUL82 inhibits STING translocation144, IE2 causes STING degradation145, and US9 
inactivates both MAVS and STING125. Furthermore, pUL83 binds AIM2 and facilitates 
the degradation of AIM2-driven inflammasomes146. A similar multi-pronged approach 
has also be observed for the gammaherpesvirus KSHV147-150. STING is also inhibited 
by oncoproteins from the nuclear DNA viruses human Adenovirus (hAD) and HPV151, 
and by Vaccinia virus (VACV), a DNA virus that resides in the cytosol152. VACV also 
inhibits DNA-PK, using its virulence factor C16 to bind the Ku70/Ku80 subunits of the 
DNA-PK complex153. Mouse cytomegalovirus (mCMV) viral inhibitor of RIP activation 
(vIRA) targets another proposed DNA sensor, DAI, to prevent the induction of 
programmed necrosis upon viral infection154. 
 Surprisingly, not only DNA viruses, but also some RNA viruses have been 
found to antagonise STING - even though they do not produce DNA or cyclic di-
nucleotides during their replication cycle. It has been reported that STING can 
function in a cGAS-independent manner during the detection of viral membrane 
fusion, for instance during infection with IAV155. This non-canonical STING signalling 
pathway is antagonised by the IAV fusion peptide (FP)156. Flaviviruses, enveloped 
viruses with a positive stranded ssRNA genome, also inhibit STING-dependent DNA 
sensing. Viral NS2B proteases encoded by Dengue virus, Zika virus, West Nile Virus 
and Japanese encephalitis virus cleave human STING protein, but not its mouse 
orthologue157,158. The dengue virus NS2B cofactor also targets cGAS for 
degradation55. This prevents the activation of an innate immune response after the 
release of mitochondrial DNA, which occurs during Dengue virus infection55,159, 
highlighting the breadth of pathogen classes that can be detected directly or 
indirectly by the DNA sensing pathway. 
 While the production of type I interferons is not always an effective strategy to 
limit bacterial infections, the activation of STING by bacterial DNA or cyclic di-
nucleotides can also promote autophagy to clear bacterial from the infected cells. For 
this reason, some intracellular bacteria also inhibit STING62. For instance, the 
Shigella effector protein IpaJ inhibits STING translocation from the ER to ERGIC38, 
and the Yersinia YopJ protein also blocks STING trafficking and causes its 
deubiquitylation160. Mycobacterium tuberculosis secretes the phosphodiesterase 
ENPP1, which degrades cGAMP and bacterial cyclic di-nucleotides, thus inhibiting 
both DNA- and CDN-induced STING activation161. Group A Streptococcus, S. 
pyogenes, subverts, rather than evades, STING signalling: it utilises its M protein to 
activate STING, resulting in the production of the anti-inflammatory cytokine IL-10 
downstream of type I interferon signalling162. In this way, the bacterium exploits the 
reciprocal antagonism between the interferon response and inflammation, and 
shapes the immune response to favour the pathogen, rather than the host.  




All pathogens, having co-evolved with their hosts, employ elaborate strategies to 
strike a fine balance between the requirements of their own life cycle, the evasion of 
host defences, and effects on pathology for the host, which can influence further 
transmission and thus the evolutionary fitness of a pathogen. As in so many fields in 
biology, much can be learnt from insights into the host-pathogen interactions that 
interfere with our cell's defences. Immunomodulatory proteins from pathogens can 
point us to their targets, which are often key signalling nodes that play a role during 
infection. While immune evasion has long been studied in human cells and mouse 
models, the investigation of innate immune signalling in reservoir hosts such as bats 
or birds, is an emerging field of research. The variation of these interactions during 
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pathogen evolution often underlies the ability of pathogens to cross species 
boundaries or to adopt new traits in transmission or virulence during emerging 
infections. Knowing more about the functions of individual immunomodulatory 
proteins is also crucial for the rational development of vaccine vectors, as for 
instance the removal of individual immune evasion factors can aid safety and 
immunogenicity of a live vaccine. As is it becoming increasingly clear that nucleic 
acid PAMPs and their PRRs also perform key roles during sterile inflammation, 
autoimmunity and even cancer treatment, the lessons we learn from our pathogens 
may ultimately have applications for the treatment and prevention of both infectious 
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Figure 1. Schematic representation of the pathogen-derived molecules employed to 
evade the intracellular RNA sensing pathway. The RNA sensors RIG-I and MDA5 
detect various RNA species, primarily those containing 5’ di- or tri-phosphates or 
long dsRNA, respectively. Some viruses modify or mask their viral RNA, for instance 
by cleaving 5’ phosphates, attaching a viral protein or “cap snatching”. Pathogens 
also inhibit RIG-I activation via degradation or blocking accessory proteins (TRIM25 
and Riplet), by direct binding with the CARD or C-terminal domains of RIG-I and by 
preventing RIG-I translocation to the mitochondria to block its interaction with MAVS. 
MDA5 is targeted in a similar fashion, often by degradation or inhibition by binding of 
virulence factors. Various viral proteins also interact with or degrade MAVS, which 
provides a further layer of evasion of the RNA sensing pathway. DENV, Dengue 
virus; EBV, Epstein-Barr virus; EBOV, Ebolavirus; HBV, hepatits B virus; hCMV, 
human cytomegalovirus; HCV, hepatitis C virus; HHV8, human herpesvirus 8; hMPV, 
human metapneumovirus; HSV-1, herpes simplex virus 1; IAV, influenza A virus; 
MERS, Middle Eastern respiratory virus; RSV, respiratory synctical virus; RV, 
rotavirus; SARS, Severe acute respiratory syndrome; WNV, West Nile virus; TOSV, 
Toscana virus; ZIKV, Zika virus. 
 
Figure 2. Schematic representation of the pathogen-derived molecules employed to 
evade the intracellular DNA sensing pathway. cGAS is a sensor of cytosolic DNA 
and the main activator of the adaptor protein, STING. Pathogens target cGAS for 
degradation, impede cGAS from binding DNA or inhibit its catalytic activity. 
Pathogens also degrade cGAMP, the second messenger produced by cGAS, as well 
as bacterial cyclic-dinucleotides (CDN). IFI16 contributes to the activation of the 
cGAS-STING pathway, and several viral proteins have been identified that inhibit its 
activation and promote its degradation. Other DNA sensors, such as DNA-PK, DAI 
and AIM2 are also targeted by viral factors that block DNA binding and activation of 
downstream pathways. Pathogens also hinder multiple aspects of STING function 
through proteolytic cleavage, degradation, blocking its translocation from the 
endoplasmic reticulum (ER) to ER-Golgi intermediate compartment (ERGIC) and 
preventing interaction with downstream signalling proteins, such as TANK-binding 
kinase 1 (TBK1). DENV, Dengue virus; hAd, human adenovirus; hCMV, human 
cytomegalovirus; HSV-1, herpes simplex virus 1; HPV18, human papillomavirus 18; 
JEV, Japanese encephalitis virus; mCMV, mouse cytomegalovirus; WNV, West Nile 
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